Dietary supplementation: the case for placebo-controlled trials

Area of Science:

• Nutritional Science
• Cancer Etiology
• Clinical Trials

Background:

• Epidemiologic and animal studies form the basis for diet-cancer hypotheses.
• Human clinical trials are essential for validating diet-cancer links and identifying preventive compounds.
• Current clinical trials in diet and cancer prevention are typically single-nutrient or broad dietary interventions.

Purpose of the Study:

• To propose an intermediate clinical trial model for diet and cancer prevention research.
• To advocate for a food-based supplement approach within a randomized double-blind placebo-controlled design.
• To highlight the suitability of this model for studying complex food components like fiber.

Main Methods:

• The paper argues for a randomized double-blind placebo-controlled clinical trial design.
• This intermediate model utilizes food-based supplements.
• It is particularly suited for investigating food components where higher-order structure is crucial for activity.

Main Results:

• The proposed model offers a more nuanced approach than single-nutrient or broad dietary interventions.
• It allows for the study of food components like fiber, where structural integrity is key.
• This design facilitates the examination of underlying mechanisms in diet-cancer relationships.

Conclusions:

• An intermediate clinical trial model using food-based supplements is recommended for diet and cancer prevention research.
• This approach is optimal for studying the role of complex food structures in cancer prevention.
• Further research using this model can enhance our understanding of diet's impact on cancer etiology.